Azitra (AZTR) Interest & Investment Income (2022 - 2026)
Azitra (AZTR) reported Interest & Investment Income of $14719.0 for Q1 2026, down 60.39% on a YoY basis from $37164.0 in Q1 2025, and up 15.34% quarter-over-quarter from $12761.0 in Q4 2025.
Azitra (AZTR) Interest & Investment Income (2022 - 2026) Analysis & Trends
Azitra has reported Interest & Investment Income for 5 years, with the latest figure at $14719.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 60.39% year-over-year to $14719.0; the trailing twelve-month figure through Mar 2026 stood at $47764.0 (down 68.6% YoY), and the FY2025 full-year result was $70209.0, down 42.71% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $14719.0, up from $12761.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $51287.0 in Q4 2024, with the low at $264.0 in Q2 2023.
- Historically, Interest & Investment Income has averaged $13334.7 across 5 years, with a median of $6216.0 in 2024.
- Annual changes were most pronounced in 2024 — Interest & Investment Income surged 12950.13% — and 2025, when it slumped 89.82%.
- Azitra's Interest & Investment Income stood at $762.0 in 2022, then tumbled by 48.43% to $393.0 in 2023, then surged by 12950.13% to $51287.0 in 2024, then tumbled by 75.12% to $12761.0 in 2025, then rose by 15.34% to $14719.0 in 2026.
- The last three Interest & Investment Income figures came in at $14719.0 (Q1 2026), $12761.0 (Q4 2025), and $4823.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | 14,719.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,719.00 |
| Dec 31, 2025 | 12,761.00 |
| Sep 30, 2025 | 4,823.00 |
| Jun 30, 2025 | 15,461.00 |
| Mar 31, 2025 | 37,164.00 |
| Dec 31, 2024 | 51,287.00 |
| Sep 30, 2024 | 47,389.00 |
| Jun 30, 2024 | 16,268.00 |
| Mar 31, 2024 | 7,609.00 |
| Dec 31, 2023 | 393.00 |
| Sep 30, 2023 | 634.00 |
| Jun 30, 2023 | 264.00 |
| Mar 31, 2023 | 285.00 |
| Dec 31, 2022 | 762.00 |
| Sep 30, 2022 | 3,201.00 |
| Jun 30, 2022 | 335.00 |